Download FREE Report Sample
Download Free samplePirubicin is suitable for the treatment of breast cancer, and has certain curative effect on head and neck cancer, bladder cancer, ureter cancer, renal pelvis cancer, ovarian cancer, cervical cancer and other malignant tumors.This drug can be directly inserted into the DNA double strand, inhibit DNA polymerase, prevent nucleic acid synthesis, in the G2 phase so that the cell can not carry on the division, resulting in the death of tumor cells.
Pirarubicin Market contains market size and forecasts of Pirarubicin in global, including the following market information:
Global Pirarubicin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pirarubicin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pirarubicin companies in 2021 (%)
The global Pirarubicin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10 Mg Dosage Forms Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pirarubicin include MicroBiopharm, Lilly, Nanjing Zhengda Tianqing Pharmaceutical, Harbin Yuheng Pharmaceutical, Shandong New Era Pharmaceutical, Zhejiang Haizheng Pharmaceutical and Shenzhen Wanle Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pirarubicin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pirarubicin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pirarubicin Market Segment Percentages, by Type, 2021 (%)
10 Mg Dosage Forms
20 Mg Dosage Forms
Global Pirarubicin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pirarubicin Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Head And Neck Cancer
Bladder Cancer
Ureteral Carcinoma
Carcinoma Of The Renal Pelvis
Ovarian Cancer
Cervical Cancer
Malignant Lymphoma
Acute Leukemia
Other
Global Pirarubicin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pirarubicin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pirarubicin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pirarubicin revenues share in global market, 2021 (%)
Key companies Pirarubicin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pirarubicin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
MicroBiopharm
Lilly
Nanjing Zhengda Tianqing Pharmaceutical
Harbin Yuheng Pharmaceutical
Shandong New Era Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Shenzhen Wanle Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
